Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
Immunotherapies represent a promising strategy for glioblastoma multiforme (GBM) treatment. Different immunotherapies include the use of checkpoint inhibitors, adoptive cell therapies such as chimeric antigen receptor (CAR) T cells, and vaccines such as dendritic cell vaccines. Antibodies have also...
Main Authors: | Stefaan W. Van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher, Wilfried Stuecker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/32 |
Similar Items
-
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
by: Stefaan W. Van Gool, et al.
Published: (2020-05-01) -
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
by: Mau-Shin Chi, et al.
Published: (2020-03-01) -
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
by: Volker Schirrmacher, et al.
Published: (2019-08-01) -
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01) -
Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit
by: Volker Schirrmacher, et al.
Published: (2020-07-01)